Patrick D. Meek

Dr. Patrick D. Meek


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2003 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Open access
PDF file
GSGlen T. Schumock
Glen T. Schumock
MBMelissa G. Butler
Melissa G. Butler
PMPatrick D. Meek
Patrick D. Meek
LVLee C. Vermeulen
Lee C. Vermeulen
BABhakti V. Arondekar
Bhakti V. Arondekar
JBJerry L. Bauman
Jerry L. Bauman
We sought to summarize and assess original evaluations of the economic impact of clinical pharmacy services published from 1996–2000, and to provide recommendations and methodologic considerations for future research. A systematic literature search was conducted to identify articles that were then blinded and randomly assigned to reviewers who confirmed inclusion and abstracted key information. Results were compared with those of a similar review of literature published from 1988–1995. In the 59 included articles, the studies were conducted across a variety of practice sites that consisted of hospitals (52%), community pharmacies and clinics (41%), health maintenance organizations (3%), and long‐term or intermediate care facilities (3%). They focused on a broad range of clinical pharmacy services such as general pharmacotherapeutic monitoring (47%), target drug programs (20%), disease management programs (10%), and patient education or cognitive services (10%). Compared with the studies of the previous review, a greater proportion of evaluations were conducted in community pharmacies or clinics, and the types of services evaluated tended to be more comprehensive rather than specialized. Articles were categorized by type of evaluation: 36% were considered outcome analyses, 24% full economic analyses, 17% outcome descriptions, 15% cost and outcome descriptions, and 8% cost analyses. Compared with the studies of the previous review, a greater proportion of studies in the current review used more rigorous study designs. Most studies reported positive financial benefits of the clinical pharmacy service evaluated. In 16 studies, a benefit:cost ratio was reported by the authors or was able to be calculated by the reviewers (these ranged from 1.7:1–17.0:1, median 4.68:1). The body of literature from this 5‐year period provides continued evidence of the economic benefit of clinical pharmacy services. Although the quality of study design has improved, whenever possible, future evaluations of this type should incorporate methodologies that will further enhance the strength of evidence of this literature and the conclusions that may be drawn from it.

2 July 2010 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
PMPatrick D. Meek
Patrick D. Meek
SESamuel D. Evang
Samuel D. Evang
MTMina Tadrous
Mina Tadrous
DRDianne Roux-Lirange
Dianne Roux-Lirange
DTDarren M. Triller
Darren M. Triller
BGBora Gumustop
Bora Gumustop

11 March 2023 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PMPatrick D. Meek
Patrick D. Meek
BHBrian Hemstreet
Brian Hemstreet

1 November 2018 in The Joint Commission Journal on Quality and Patient Safety
Verified
Journal Article
Closed access
DTDarren Triller
Darren Triller
AMAnne Myrka
Anne Myrka
JGJohn Gassler
John Gassler
KRKelly Rudd
Kelly Rudd
PMPatrick D. Meek
Patrick D. Meek
JAJack Ansell
Jack Ansell

1 March 2009 in American Journal of Health-System Pharmacy
Verified
Journal Article
Closed access
PDF file
JHJames M. Hoffman
James M. Hoffman
PMPatrick D. Meek
Patrick D. Meek
DTDaniel R. Touchette
Daniel R. Touchette
LVLee C. Vermeulen
Lee C. Vermeulen
GSGlen T. Schumock
Glen T. Schumock
The recent AJHP article by De Rijdt et al.[1][1] on the economic effects of clinical pharmacy interventions was of particular interest to us.[1][1] Knowing “what works” and what is most effective in health care is crucial for deciding which interventions are the most rational and efficient,[2][2

30 April 2008 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
PMPatrick D. Meek
Patrick D. Meek
ACAndrew D. Coates
Andrew D. Coates
LNLisa Norelli
Lisa Norelli
DWDaniel P. Woodcock
Daniel P. Woodcock
OSOladayo Shobola
Oladayo Shobola
BKBeatrice Kovasznay
Beatrice Kovasznay